717
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Effects of the copper oxide nanoparticles (CuO NPs) on Galleria mellonella hemocytes

ORCID Icon & ORCID Icon
 

Abstract

In this study, 38 nm-sized and flake-like-shaped CuO NPs (10, 50, 100, 150 μg/10 µl/larva) were force-fed to fourth instar (100 ± 20 mg) Galleria mellonella (Lepidoptera: Pyralidae) larvae under the laboratory conditions. The effects of CuO NPs on total hemocyte counts (THCs) and the frequency of viable, mitotic, apoptotic, necrotic, and micronucleated hemocyte indices were detected with the double-staining protocol by hematoxylin and eosin (H&E) stains. The total hemocyte counts (THCs) did not change significantly in G. mellonella larvae at all concentrations for 24 h and 72 h post-force-feeding treatment. The ratio of viable hemocytes decreased at 50, 100, 150 μg/10 µl concentrations in 24 h and 72 h when compared with untreated larvae. The increases in the percentage of mitotic and micronucleated hemocytes were statistically significant at 150 μg/10 µl in 24 h. The results showed that high concentrations (>10 μg/10 µl) of CuO NPs increased the percentage of apoptotic hemocytes in 24 h. 100 and 150 μg/10 µl of CuO NPs caused a significant increase in the percentage of necrotic hemocytes in 24 h. The decrease in the percentage of mitotic hemocytes at 10, 100 and 150 μg/10 µl in 72 h was statistically significant. Apoptotic hemocytes increased and were found to be higher at 100 and 150 μg/10 µl of CuO NPs in 72 h in comparison with the untreated larvae. Finally, we observed an increase in the percentage of necrotic hemocytes at 150 μg/10 µl in 72 h.

Acknowledgments

We would like to express our deepest gratitude to officials of Metallurgical and Materials Engineering Department in Faculty of Engineering at Marmara University for XRD analysis of CuO NPs. We also wish to thank Zeliha YUKSEL, translator and proofreader, for proofreading the manuscript before delivery.

Disclosure statement

The authors declare that they have no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.